Chung SC, Sofat R, Acosta-Mena D et al (2021) Atrial fibrillation epidemiology, disparity and healthcare contacts: a population-wide study of 5.6 million individuals. Lancet Reg Health Eur 7:100157

Article  PubMed  PubMed Central  Google Scholar 

Elsheikh S, Hill A, Irving G et al (2023) Atrial fibrillation and stroke: state-of-the-art and future directions. Curr Probl Cardiol 49:102181

Article  PubMed  Google Scholar 

Wu J, Nadarajah R, Nakao YM et al (2023) Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation. Eur Heart J 44:4422–4431

Article  PubMed  PubMed Central  Google Scholar 

Burdett P, Lip GYH (2022) Atrial fibrillation in the Uk: Predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes 8:187–194

Article  PubMed  Google Scholar 

Maeda T, Nishi T, Funakoshi S et al (2021) Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (f-create project). Heart 107:217–222

Article  PubMed  Google Scholar 

Krittayaphong R, Chichareon P, Komoltri C et al (2023) Predicting heart failure in patients with atrial fibrillation: a report from the prospective cool-af registry. J Clin Med, 12

Ruddox V, Sandven I, Munkhaugen J et al (2017) Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol 24:1555–1566

Article  PubMed  PubMed Central  Google Scholar 

An Y, Ogawa H, Yamashita Y et al (2019) Causes of death in Japanese patients with atrial fibrillation: the fushimi atrial fibrillation registry. Eur Heart J Qual care Clin Outcomes 5:35–42

Article  PubMed  Google Scholar 

Krittayaphong R, Boonyapiphat T, Aroonsiriwattana S et al (2023) Causes of death of patients with non-valvular atrial fibrillation in asians. PLoS ONE 18:e0282455

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rasmussen PV, Pallisgaard JL, Hansen ML et al (2022) Treatment of older patients with atrial fibrillation by morbidity burden. Eur Heart J Qual care Clin Outcomes 8:23–30

Article  PubMed  Google Scholar 

Proietti M, Marzona I, Vannini T et al (2019) Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use. Mayo Clin Proc 94:2427–2436

Article  CAS  PubMed  Google Scholar 

Lip GYH (2017) The abc pathway: an integrated approach to improve af management. Nat Reviews Cardiol 14:627–628

Article  Google Scholar 

Romiti GF, Pastori D, Rivera-Caravaca JM et al (2022) Adherence to the ‘atrial fibrillation better care’ pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients. Thromb Haemost 122:406–414

Article  PubMed  Google Scholar 

Krittayaphong R, Winijkul A, Methavigul K et al (2023) Impact of achieving blood pressure targets and high time in therapeutic range on clinical outcomes in patients with atrial fibrillation adherent to the atrial fibrillation better care pathway: a report from the cool-af registry. J Am Heart Association 12:e028463

Article  Google Scholar 

Camacho EM, Lip GYH (2023) Estimating the impact of implementing an integrated care management approach with atrial fibrillation better care (abc) pathway for patients with atrial fibrillation in England from 2020–2040. European heart journal Quality of care & clinical outcomes

Chao TF, Joung B, Takahashi Y et al (2022) 2021 focused update consensus guidelines of the asia pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost 122:20–47

Article  PubMed  Google Scholar 

Li YG, Borgi M, Lip GY (2018) Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies. Eur Heart J Acute Cardiovasc Care 10:2048872618801763

PubMed  Google Scholar 

Hindricks G, Potpara T, Dagres N et al (2020) 2020 esc guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of cardio-thoracic surgery (eacts). Eur Heart J 42:373–498

Article  Google Scholar 

Schulman S, Kearon C et al (2005) Subcommittee on Control of Anticoagulation of the S,. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Journal of thrombosis and haemostasis: JTH, 3: 692–694

Rosendaal FR, Cannegieter SC, van der Meer FJ et al (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236–239

Article  CAS  PubMed  Google Scholar 

Bassand JP, Apenteng PN, Atar D et al (2021) Garfield-af: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke. Future Cardiol 17:19–38

Article  CAS  PubMed  Google Scholar 

Chan YH, See LC, Tu HT et al (2018) Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in asians with nonvalvular atrial fibrillation. J Am Heart Association, 7

Romiti GF, Guo Y, Corica B et al (2023) Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mafa-ii randomized clinical trial. Thromb Haemost

Treewaree S, Lip GYH, Krittayaphong R (2023) Non-vitamin k antagonist oral anticoagulant, warfarin, and abc pathway adherence on hierarchical outcomes: Win ratio analysis of the cool-af registry. Thromb Haemost

Writing Committee M, Joglar JA, Chung MK et al (2023) 2023 acc/aha/accp/hrs guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol

Proietti M, Romiti GF, Corica B et al (2023) Features of clinical complexity in European patients with atrial fibrillation: a report from a European observational prospective af registry. Curr Probl Cardiol 48:101752

Article  PubMed  Google Scholar 

Hori H, Fukuchi T, Sugawara H (2021) Anticoagulant therapy for frail patients with atrial fibrillation. Intern Med 60:495–506

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilkinson C, Todd O, Clegg A et al (2019) Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. Age Ageing 48:196–203

Article  PubMed  Google Scholar 

Proietti M, Romiti GF, Raparelli V et al (2022) Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients. Ageing Res Rev 79:101652

Article  CAS  PubMed  Google Scholar 

Reig-Garcia G, Camara-Liebana D, Jimenez-Quinones R et al (2022) Control of therapeutic levels of anticoagulation and associated factors: a prospective cohort study. J Prim Care Community Health 13:21501319221129935

Article  PubMed  PubMed Central  Google Scholar 

Zhao S, Zhao H, Wang X et al (2017) Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China. Patient Prefer Adherence 11:213–220

Article  PubMed  PubMed Central  Google Scholar 

Pandey AK, Xu K, Zhang L et al (2020) Lower versus standard inr targets in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Thromb Haemost 120:484–494

Article  PubMed  Google Scholar 

Eikelboom JW, Weitz JI (2023) Direct oral anticoagulants in the very elderly. Thromb Haemost 123:377–379

Article  PubMed  PubMed Central  Google Scholar 

Trinks-Roerdink EM, Geersing GJ, van den Dries CJ et al (2023) Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the all-in trial. PLoS ONE 18:e0292586

Article  CAS  PubMed  PubMed Central  Google Scholar